Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma

European Journal of Nuclear Medicine

Volumn 23, Issue 10, 1996, Pages 1378-1383

  Yeh, Shin Hwa ^a   Liu, Ren Shyan ^a   Wu, Liang Chih ^a   Yang, David J ^b   Yen, Sang Hue ^a   Chang, Chi Wei ^a   Yu, Tong Wei ^a   Chou, Kou Liang ^a   Chen, Kuang Y ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fluorine 18 fluoromisonidazole; Hypoxia; Nasopharyngeal carcinoma; Tumour to muscle retention ratio

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; FLUORINE 18; MISONIDAZOLE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOXIA; MALE; MUSCLE LEVEL; NASOPHARYNX; NASOPHARYNX CARCINOMA; NECK; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY;

CARCINOMA; CASE-CONTROL STUDIES; CELL HYPOXIA; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NECK MUSCLES; RADIATION-SENSITIZING AGENTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029800972     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01367595     Document Type: Article

References (29)

1. Mottram JC. Factors of importance in the radiosensitivity of tumors. Br J Radiol 1936; 9: 606-614.
2. Powers WE, Tolmach LJ. A multi-component x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 1963; 197: 710-711.
3. Moulder JE, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int J Radiat Oncol Biol Phys 1984; 10: 695-712.
4. Gatenby RA, Kessler HB, Rosenblum SJ, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 831-838.
5. Cater DB, Silver LA. Quantitative measurements of oxygen tension in normal tissues and in the tumors of patients before and after radiotherapy. Acta Radiol 1960; 53: 233-256.
6. 2 histography as predictive assay in advanced cancer of the uterine cervix. In: Vaupel P et al., eds. Oxygen transport to tissue XV. New York: Plenum Press; 1994: 445-450.
7. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia: review article. Eur J Nucl Med 1995; 22: 265-280.
8. Webster LT. Drugs used in chemotherapy of protozoal infections. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics, 8th edn. New York: Pergamon Press 1990; 1002-1004.
9. Edwards DI. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 1993; 31: 9-20.
10. Brown JM. Hypoxic cell radiosensitisers: Where next? Int J Radiat Oncol Biol Phys 1989; 16: 987-993.
11. Chapman JD, Franko AJ, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer 1981; 43: 546-550.
12. 18F]fluoromisonidazole in ischemic myocardium. J Nucl Med 1989; 30: 194-201.
13. Rasey JS, Grunbaum Z, Magee S, et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiat Res 1987; 111: 292-304.
14. Rasey JS, Koh W, Grierson JR, Grunbaum Z, Krohn KA. Radiolabeled fluoromisonidazole as in imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989; 17: 985-991.
15. Grierson JR, Link JM, Mathis CA, Rasey JS, Krohn KA. A radiosynthesis of fluorine-18 fluoromisonidazole. J Nucl Med 1989; 30: 343-350.
16. Grunbaum Z, Freauff SJ, Krohn KA, et al. Synthesis and characterization of congeners of misonidazole for imaging hypoxia. J Nucl Med 1987; 28: 68-75.
17. Rasey JS, Grunbaum Z, Shankland EG, et al. Imaging tumor hypoxia with [F-18]fluoromisonidazole [abstract]. J Nucl Med 1987; 28: 594.
18. Rasey JS, Nelson NJ, Chin L, et al. Characterization of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res 1990; 122: 301-308.
19. Koh WJ, Rasey JS, Evans ML, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1991; 22: 199-212.
20. Valk PE, Mathis CA, Prados MD, et al. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 1992; 33: 2133-2137.
21. American Joint Committee on Cancer Manual for Staging Cancer, 4th edn. Philadelphia: J.B. Lippincott; 1992; 37.
22. 18F]fluoromisonidazole). Pharm Res 1994; 11: 466-469.
23. Cater DB. Oxygen tension in neoplastic tissues. Tumori 1964; 50: 435-444.
24. Varghese AJ, Whitmore GF. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity in misonidazole. Cancer Res 1980; 40: 2165-2169.
25. Jerabek PA, Patrick TB, Kilbourn MR, Dischino DD, Welch MJ. Synthesis and biodistribution of F-18-labeled fluoronitroimidazoles: potential markers of hypoxic tissue. Appl Radiat Isot 1986; 37: 599-605.
26. Koh WJ, Rasey JS, Grierson JR, et al. Hypoxia imaging of tumors using [F-18] fluoromisonidazole. J Nucl Med 1989; 30: 789.
27. Koh WJ, Rasey JS, Evans ML, et al. Imaging human tumor hypoxia using [F-18] fluoromisonidazole. J Nucl Med 1991; 32: 955.
28. Koh WJ, Rasey JS, Grierson JR, et al. Hypoxia imaging of tumors using [F-18] fluoromisonidazole [abstract]. J Nucl Med 1989; 30: 789.
29. Chapman JD. Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncol 1991; 20 Suppl 1: 13-19.